Humanin

uestion": "What is Humanin?", "answer": "Humanin is a small neuroprotective peptide encoded by mitochondrial DNA. It plays a role in cell survival, preventing cell death, and protecting against various cellular stresses, particularly in the brain and heart. It's being studied for its potential in age-related diseases. (PubChem)"}, {"question": "Is Humanin a controlled substance?", "answer": "No, Humanin is not a controlled substance. It is a research peptide and is not currently approved as a drug by regulatory bodies for human use outside of clinical trials. (General regulatory status)"}, {"question": "What are the primary benefits of Humanin being studied?", "answer": "Research suggests Humanin may offer benefits in neuroprotection (especially for Alzheimer's), improving mitochondrial health, anti-aging effects, cardiovascular protection, and metabolic regulation by improving insulin sensitivity. These benefits are mainly from preclinical studies. (NIH ODS)"}, {"question": "How is Humanin typically administered?", "answer": "Humanin is typically administered via injection in research settings, as peptides are generally poorly absorbed orally. The specific route and frequency would depend on the research protocol or future clinical guidelines. (DrugBank, general peptide administration)"}, {"question": "Are there any side effects or warnings for Humanin?", "answer": "Due to limited human clinical data, a full side effect profile is not established. Preclinical studies suggest it's generally well-tolerated. Warnings relate to the lack of long-term human safety data, potential individual variability, and purity concerns for research-grade materials. Always consult a clinician before use. (General pharmacological principles, limited data)"}]